Best Biotechnology Stocks

Biotech stocks open the door to investing in innovation that’s shaping the future of healthcare. From pioneering drug developers to specialized firms in genetic engineering and diagnostics, this sector offers exposure to breakthroughs with the potential for transformative impact—and strong returns. These stocks are known for their potential for high growth but also come with significant volatility due to the complex nature of biotechnological development and regulatory environments.

The list below highlights some of the most widely followed biotech stocks in today’s market. It features a range of companies—from established leaders with approved therapies to up-and-coming firms advancing promising clinical pipelines. View each stock's current price, PE ratio, volume, and recent indicators of potential movement.

On This Page:Resources FAQ Why Invest in Biotech Stocks More Stock Ideas

Company	Current Price	P/E Ratio	Market Cap	Volume	Average Volume	Indicator(s)
ABBV AbbVie	$215.64 +1.3%	106.23	$381.00 billion	5.45 million	6.88 million	Positive News Analyst Upgrade
TMO Thermo Fisher Scientific	$480.62 -2.7%	26.42	$178.61 billion	1.77 million	2.38 million	Positive News Analyst Forecast
DHR Danaher	$175.97 -2.2%	34.04	$124.54 billion	2.91 million	4.37 million	Analyst Downgrade
VRTX Vertex Pharmaceuticals	$425.09 -3.0%	25.21	$107.89 billion	1.15 million	1.38 million	Trending News Analyst Downgrade
GSK GSK	$49.06 -0.5%	12.75	$99.56 billion	2.94 million	4.87 million	Dividend Cut Analyst Downgrade
BE Bloom Energy	$302.85 +10.7%	N/A	$86.14 billion	12.96 million	11.15 million	Trending News
LITE Lumentum	$1,029.15 +13.7%	190.58	$80.07 billion	8.10 million	6.01 million	Trending News Insider Trade Gap Down
COR Cencora	$265.43 +0.3%	20.35	$51.64 billion	1.45 million	1.55 million
ARGX argenex	$802.17 -4.1%	35.72	$49.89 billion	359,242	350,638	Analyst Forecast
TAK Takeda Pharmaceutical	$15.19 +0.0%	38.96	$48.35 billion	2.38 million	3.03 million
Stranded On The Flood Plains of History (Ad) The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar. Read Porter's full briefing and get the ticker names today
ALNY Alnylam Pharmaceuticals	$286.12 -3.2%	78.17	$38.20 billion	1.04 million	1.26 million	Positive News
RPRX Royalty Pharma	$54.01 -2.1%	36.74	$31.10 billion	3.57 million	3.67 million	Positive News
IQV IQVIA	$180.52 -3.4%	22.37	$30.13 billion	1.68 million	1.92 million	Gap Down
VEEV Veeva Systems	$182.93 -3.0%	33.81	$29.88 billion	3.79 million	2.68 million	Positive News Upcoming Earnings Gap Down
CTSH Cognizant Technology Solutions	$55.14 -3.5%	11.99	$26.13 billion	9.20 million	6.99 million	Trending News Analyst Forecast
FN Fabrinet	$704.45 +13.2%	60.52	$25.24 billion	1.08 million	778,777
ILMN Illumina	$162.55 -1.1%	29.55	$24.59 billion	2.13 million	1.87 million	Trending News Analyst Forecast Insider Trade Gap Down
UTHR United Therapeutics	$540.05 -0.8%	19.94	$22.92 billion	423,808	481,179	Insider Trade
BNTX BioNTech	$89.14 -2.8%	N/A	$22.54 billion	966,928	1.07 million	Analyst Forecast Gap Up
IFF International Flavors & Fragrances	$73.20 -1.4%	22.38	$18.69 billion	1.89 million	1.83 million	Analyst Forecast
MRNA Moderna	$45.64 -0.9%	N/A	$18.11 billion	5.68 million	9.31 million	Trending News Gap Up
MEDP Medpace	$445.59 -1.3%	28.01	$12.73 billion	298,815	366,901	Trending News Insider Trade
RVTY Revvity	$100.28 -0.2%	47.98	$11.19 billion	1.42 million	1.36 million	Analyst Forecast Analyst Revision Gap Down
ICLR Icon	$137.54 -0.4%	22.33	$11.11 billion	1.24 million	1.59 million	Earnings Report Upcoming Earnings Analyst Forecast Gap Down
SUZ Suzano	$8.07 -0.7%	4.80	$10.00 billion	4.11 million	3.34 million
KRYS Krystal Biotech	$293.21 -1.6%	39.20	$8.64 billion	334,015	292,310	Analyst Forecast
CRL Charles River Laboratories International	$174.56 -4.1%	N/A	$8.41 billion	752,141	948,372	Analyst Revision
BIO.B Bio-Rad Laboratories	$304.15	50.11	$8.14 billion	17	281
IBB iShares Biotechnology ETF	$169.37	N/A	$7.89 billion	1.95 million	1.69 million	Positive News
IBRX ImmunityBio	$7.23 -0.1%	N/A	$7.57 billion	13.65 million	28.94 million	Analyst Forecast
PCVX Vaxcyte	$47.41 -3.1%	N/A	$6.85 billion	1.50 million	1.42 million	Gap Up
LEGN Legend Biotech	$36.28 +42.2%	N/A	$6.74 billion	14.61 million	2.44 million	News Coverage Analyst Forecast Gap Up High Trading Volume
SYRE Spyre Therapeutics	$69.16 -2.0%	N/A	$6.01 billion	814,331	937,705	Positive News Gap Up
ABVX Abivax	$72.50 -44.1%	N/A	$5.78 billion	16.07 million	1.32 million	Trending News Analyst Forecast Gap Up High Trading Volume
TGTX TG Therapeutics	$36.64 -2.1%	12.81	$5.61 billion	1.53 million	2.05 million
COGT Cogent Biosciences	$32.76 -5.9%	N/A	$5.60 billion	4.27 million	2.09 million	High Trading Volume
APGE Apogee Therapeutics	$78.71 -0.7%	N/A	$4.87 billion	1.11 million	959,419	News Coverage
NNNN Anbio Biotechnology	$32.12 +6.5%	N/A	$4.62 billion	13,476	43,624	News Coverage Short Interest Increase Gap Up
DNTH Dianthus Therapeutics	$81.57 -8.8%	N/A	$4.46 billion	1.06 million	877,083	Positive News Gap Up
CELC Celcuity	$91.42 -25.7%	N/A	$4.46 billion	5.68 million	894,315	Analyst Forecast Gap Up High Trading Volume
Musk is burning $2.5 billion a quarter on AI. One company holds the key. (Ad) SpaceX's S-1 filing reveals $7.7 billion spent on AI infrastructure in a single quarter - not chips, not software, but power infrastructure. The filing shows $23.85 billion in servers and $14 billion in construction in progress, all dependent on one company's hardware. Without this supplier, Colossus doesn't run and the $1.25 billion Anthropic pays monthly stops flowing. The stock is still trading like no one has read the filing - but analyst Dylan Jovine has, and he's releasing the name at no cost. Read the S-1 breakdown and get the company name free
TWST Twist Bioscience	$70.15 +3.4%	N/A	$4.37 billion	1.09 million	1.37 million	Positive News
JTEK JPMorgan U.S. Tech Leaders ETF	$109.88	47.07	$4.33 billion	294,798	302,743	Positive News
RDW Redwire	$20.56 -0.6%	N/A	$3.95 billion	36.03 million	30.27 million	Analyst Downgrade Gap Up
TPC Tutor Perini	$74.21 -0.1%	50.48	$3.90 billion	503,790	593,763	Gap Down
TXG 10x Genomics	$30.71 +3.8%	N/A	$3.90 billion	3.08 million	2.66 million	Gap Down
SXI Standex International	$288.86 +2.3%	35.18	$3.50 billion	215,932	176,372	Gap Down
ORKA Oruka Therapeutics	$55.23 +0.4%	N/A	$3.33 billion	1.16 million	1.06 million	Positive News Analyst Forecast Gap Up
TNGX Tango Therapeutics	$21.50 -6.9%	N/A	$3.11 billion	3.18 million	3.24 million	Gap Down
DNLI Denali Therapeutics	$19.35 -5.2%	N/A	$3.07 billion	1.73 million	1.75 million	Positive News
BEAM Beam Therapeutics	$28.96 -7.0%	N/A	$2.98 billion	1.77 million	2.03 million	Gap Down
KLRA Kailera Therapeutics	$22.59 -2.5%	N/A	$2.93 billion	443,627	660,723	Analyst Downgrade
HTGC Hercules Capital	$15.52 -1.1%	8.77	$2.90 billion	1.78 million	2.35 million
DYN Dyne Therapeutics	$17.24 -7.5%	N/A	$2.85 billion	1.88 million	1.98 million
ADPT Adaptive Biotechnologies	$15.14 -0.6%	N/A	$2.42 billion	1.63 million	1.91 million	Positive News
VERA Vera Therapeutics	$31.26 -7.9%	N/A	$2.24 billion	1.72 million	1.13 million	News Coverage Analyst Forecast Gap Up
IMNM Immunome	$19.34 -6.9%	N/A	$2.19 billion	2.83 million	1.37 million	Analyst Downgrade Gap Up High Trading Volume
BCRX BioCryst Pharmaceuticals	$8.34 -2.7%	N/A	$2.12 billion	4.51 million	5.09 million	Positive News
DHC Diversified Healthcare Trust	$8.50 +3.5%	N/A	$2.06 billion	2.63 million	1.88 million	Positive News
THR Thermon Group	$61.20 +0.1%	45.67	$2.02 billion	2.87 million	810,284	News Coverage Analyst Upgrade Gap Up High Trading Volume
RXRX Recursion Pharmaceuticals	$3.61 -4.7%	N/A	$1.91 billion	20.72 million	17.09 million	Gap Down
IOVA Iovance Biotherapeutics	$4.10 +3.4%	N/A	$1.83 billion	12.69 million	15.10 million	News Coverage Gap Up
LKFT Lakefront Biotherapeutics American Depositary Shares	$27.27 -1.0%	N/A	$1.80 billion	303,524	147,435	High Trading Volume
NBTX Nanobiotix	$36.76 -3.3%	N/A	$1.78 billion	53,920	59,849	Short Interest Increase Gap Up
ZYME Zymeworks	$24.11 -1.8%	N/A	$1.76 billion	887,443	717,158
AAPG Ascentage Pharma Group International	$18.45 -3.3%	N/A	$1.72 billion	9,004	4,367	High Trading Volume
TYRA Tyra Biosciences	$28.66 -5.7%	N/A	$1.70 billion	716,748	934,538	News Coverage Gap Up
NVAX Novavax	$10.21 -2.9%	N/A	$1.68 billion	4.63 million	5.03 million	Analyst Upgrade Gap Up
RAPP Rapport Therapeutics	$34.90 -6.0%	N/A	$1.67 billion	309,432	336,119	Analyst Forecast Gap Up
VRDN Viridian Therapeutics	$15.87 -6.4%	N/A	$1.64 billion	2.41 million	2.28 million	Positive News Gap Up
CAPR Capricor Therapeutics	$27.34 -4.2%	N/A	$1.58 billion	895,796	1.23 million	Gap Up
GENB Generate Biomedicines	$11.97 -7.7%	N/A	$1.53 billion	1.21 million	543,243	High Trading Volume
GLUE Monte Rosa Therapeutics	$17.74 -9.8%	N/A	$1.50 billion	972,489	1.32 million	News Coverage Gap Down
IMCR Immunocore	$29.56 +1.5%	N/A	$1.50 billion	599,847	424,031
ANAB AnaptysBio	$51.26 -3.5%	N/A	$1.49 billion	819,849	780,700	Positive News Gap Up
AMLX Amylyx Pharmaceuticals	$13.29 -5.5%	N/A	$1.48 billion	1.65 million	1.21 million
VIR Vir Biotechnology	$8.74 -3.2%	N/A	$1.47 billion	1.41 million	2.80 million
FTRE Fortrea	$15.36 -2.5%	N/A	$1.45 billion	1.37 million	1.53 million	Gap Down
DMRA Damora Therapeutics, Inc. Common Stock	$22.95 -7.6%	N/A	$1.41 billion	288,663	265,949	News Coverage
SEPN Septerna	$29.94 -0.1%	N/A	$1.35 billion	603,615	314,544
URGN Urogen Pharma	$26.54 -1.8%	N/A	$1.29 billion	727,142	812,694	Gap Up
COAG Hemab Therapeutics	$27.47 +1.3%	N/A	$1.28 billion	194,537	221,907	Short Interest Increase
HQH abrdn Healthcare Investors	$19.17 -2.7%	N/A	$1.10 billion	209,770	170,346
WVE WAVE Life Sciences	$5.69 -9.1%	N/A	$1.09 billion	4.30 million	4.29 million	Gap Up
AZTA Azenta	$23.43 +1.0%	N/A	$1.08 billion	989,496	1.02 million	Gap Down
OCSL Oaktree Specialty Lending	$12.17 +0.8%	21.35	$1.07 billion	493,813	891,388	Positive News
EVO Evotec	$2.95 -3.9%	N/A	$1.05 billion	39,558	117,398	Gap Down
SANA Sana Biotechnology	$3.24 +0.9%	N/A	$901.67 million	3.21 million	3.11 million	Analyst Upgrade Gap Up
TRNS Transcat	$90.56 +2.8%	156.14	$845.92 million	151,362	148,125	Positive News Earnings Report Analyst Revision Gap Down
DRUG Bright Minds Biosciences	$76.78 -5.2%	N/A	$747.07 million	508,386	189,005	Analyst Forecast High Trading Volume
AVTX Avalo Therapeutics	$13.96 -11.4%	N/A	$733.88 million	1.60 million	1.07 million	Positive News
Stranded On The Flood Plains of History (Ad) The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar. Read Porter's full briefing and get the ticker names today
REPL Replimune Group	$8.87 -1.4%	N/A	$732.42 million	6.20 million	4.85 million	Analyst Forecast
SLRC SLR Investment	$13.25 -0.7%	8.08	$722.92 million	244,756	367,566	Positive News
EVMN Evommune	$19.82 -10.6%	N/A	$713.95 million	387,795	519,921	News Coverage Insider Trade
AURA Aura Biosciences	$6.90 -4.0%	N/A	$713.39 million	479,138	369,540	Gap Up
RLMD Relmada Therapeutics	$6.42 -6.3%	N/A	$673.39 million	1.91 million	1.38 million	Gap Up
CLYM Climb Bio	$11.20 -5.1%	N/A	$641.32 million	1.42 million	720,042	Gap Down
PHR Phreesia	$10.34 -3.0%	68.90	$638.43 million	1.89 million	1.87 million	Trending News Earnings Report Analyst Upgrade Gap Down
DNA Ginkgo Bioworks	$9.31 +1.8%	N/A	$607.91 million	2.87 million	1.18 million	Gap Down High Trading Volume
CABA Cabaletta Bio	$3.68 +0.3%	N/A	$600.04 million	3.44 million	3.27 million	Analyst Upgrade Gap Up
PRME Prime Medicine	$3.21 -5.6%	N/A	$579.79 million	3.31 million	2.67 million	Gap Down

Resources

Frequently Asked Questions

Biotech stocks represent shares of companies in the biotechnology sector, which focuses on using biological processes, organisms, or systems to develop products that improve health, fight diseases, and benefit the environment. This sector includes companies that work on drug development, genetic research, biologically derived materials, and more. Due to the innovative and often breakthrough nature of their work, biotech stocks are known for their volatility but also for their potential to offer substantial returns.

Prominent players in the biotech sector include large, well-established companies such as Amgen, Gilead Sciences, and Biogen, which have multiple products on the market and solid research pipelines. Younger companies like Moderna and Regeneron are also notable, especially for their roles in developing treatments and vaccines at an accelerated pace in response to global health crises. These companies represent a mix of stable investments and high-growth potentials within the biotech industry.

While biotech exists in other areas, the majority of the biotech stocks are in the medical and agricultural sectors. Investors might choose individual stocks of companies they believe have potential based on their pipelines or existing products. However, due to the high risk associated with the biotech sector, many opt to diversify their exposure through biotech ETFs or mutual funds, which include a range of companies from startups to established leaders. This strategy can mitigate some of the risks while allowing investors to benefit from the sector's overall growth.

Before investing in biotech stocks, consider the unique risks of this sector, including high development costs, regulatory hurdles, and the binary nature of clinical trial results, which can dramatically affect a company's stock price. Investors should be prepared for volatility and have a tolerance for risk. It is also crucial to research and understand the specific focus areas of biotech companies, as these can vary widely from medical devices and pharmaceuticals to agricultural and environmental biotechnologies. Consulting with a financial advisor who understands the biotech sector can provide valuable insights and guidance tailored to your financial goals.

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Best Biotechnology Stocks

Resources

Frequently Asked Questions

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Best Biotechnology Stocks

Resources

Frequently Asked Questions

What Are Biotech Stocks?

What Are the Leading Companies in the Biotech Sector?

How Can I Invest in Biotech Stocks?

What Should I Consider Before Investing in Biotech Stocks?

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools